Article metrics

Download PDFPDF

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to October 2020

AbstractFullPdf
Dec 2019221
Jan 202013133
Feb 2020434311
Mar 2020515117
Apr 202044447
May 2020606011
Jun 202035357
Jul 2020232317
Aug 2020343426
Sep 2020919137
Oct 2020898735
Total485483172